Cognition Therapeutics to Report Biomarker Results from – GlobeNewswire March 25, 2025 PURCHASE, N.Y., March 25, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage ...